Outcomes4Me is a 2024 Fast Company World Changing Idea! Learn more >>

Outcomes4Me is a CancerX founding member

Written By:

CancerX and Outcomes4Me

Today at the American Society of Clinical Oncology (ASCO) annual meeting, CancerX–– co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe)––announced its founding members. Along with more than 90 other founding members of CancerX, Outcomes4Me is proud to support the efforts of this partnership.

At Outcomes4Me, we believe all patients deserve equitable and direct access to the latest, evidence-based information about innovation in cancer research, including the latest treatment options, opportunities to participate in relevant clinical trials, and access to recommended genetic testing–all personalized to each patient’s unique diagnosis. We’re honored to join the CancerX partnership because we know that digital health that allows for direct-to-patient clinical information, in a relevant and easy-to-understand format, is key to ensuring patients have the knowledge and power they need to take an active role in managing and navigating their disease. Patients deserve to have the resources they need in order to play a central role in improving their own health outcomes.


What is CancerX?

CancerX was announced by President Joe Biden in February 2023 as part of The White House’s reignited national Cancer Moonshot initiative. Led by the Office of the National Coordinator for Health Information Technology (ONC) branch of the Department of Health and Human Services (HHS), CancerX is a National Innovation Accelerator Initiative designed to bring digital solutions to healthcare to improve cancer patient outcomes.

CancerX unites diverse stakeholders and innovators from across public and private sectors to unleash the power of digital innovation to ease the burden of cancer. The initiative accelerates the development of biotech and digital health solutions to support the goals of the national Cancer Moonshot to close the screening gap, address environmental exposure, decrease preventable cancers, and bring cutting-edge research to patients.

On May 25, ASCO published two online articles from CancerX that further explain the mission of the initiative and plans to achieve its goals:


How you can help support Outcomes4Me’s role in CancerX

Patients are central to driving innovation and supporting cancer research. De-identified medical data helps researchers understand real-world effects of cancer treatments so they can continue to improve upon current options and develop new, life-saving treatments.

Outcomes4Me partners with leading researchers and institutions to accelerate medical breakthroughs that benefit cancer patients. When you securely share your medical history with us, you’re helping to enable research that can improve treatment options and empower fellow patients. Together with other CancerX founders, we can help build a future that’s free from the burden of cancer.

Related Articles

The life expectancy for stage 4 non-small cell lung cancer (NSCLC) without treatment can vary...
Metastasis to the brain is a possible complication of non-small cell lung cancer (NSCLC) and...